02196 FOSUN PHARMA
Closed Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2024) | |||
| Current | 0.92X | Oper Margin | 9.7% |
|---|---|---|---|
| LT Debt/Equity | 27.5% | Net Margin | 6.8% |
| Total Debt/Equity | 76.1% | Return on Equity | 5.9% |
| Price/Book | 1.40X | Return on Assets | 2.4% |
| (HKD 26.440) | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
| Net Profit (MHKD) | 2,945.77 | 2,643.74 | 4,189.90 | 5,783.69 | 4,347.03 |
|---|---|---|---|---|---|
| Net Profit Growth (%) | +11.4 | -36.9 | -27.6 | +33.1 | +17.1 |
| Earnings Per Share (HKD) | 1.103 | 0.99 | 1.607 | 2.257 | 1.696 |
| Earnings Per Share Growth (%) | +11.4 | -38.4 | -28.8 | +33.1 | +17.1 |
| Dividend Per Share (HKD) | 0.350 | 0.300 | 0.460 | 0.660 | 0.520 |
| P/E* (X) | 23.97 | 26.70 | 16.45 | 11.72 | 15.59 |
| Yield (%) | 1.32 | 1.13 | 1.74 | 2.50 | 1.97 |
| Dividend Share (%) | 31.73 | 30.29 | 28.63 | 29.25 | 30.66 |
| Book NAV (HKD) | 18.894 | 18.826 | 18.685 | 18.678 | 17.105 |
| Auditors' Opinion | Unqualified | Unqualified | Unqualified | Unqualified | Unqualified |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2025-09-08 21:40:20
Latest Result
| (RMBMn) | 2025-06 | 2024-06 | Chg* (%) | 2023-06 |
| Cover Period (mths) | 6 | 6 | NA | 6 |
|---|---|---|---|---|
| Turnover | 19,426 | 20,383 | -4.7 | 21,316 |
| Operating Result | 843.715 | 850.918 | -0.8 | 1,395 |
| Associates | 929.661 | 841.32 | +10.5 | 1,022 |
| Profit Before Taxation | 2,718 | 1,931 | +40.8 | 2,662 |
| Taxation | 618.271 | 381.469 | +62.1 | 610.245 |
| Profit /( Loss) After Taxation | 2,100 | 1,550 | +35.5 | 2,051 |
| Minority Interests | 398.243 | 324.933 | +22.6 | 267.753 |
| Net Profit | 1,702 | 1,225 | +38.9 | 1,784 |
| Earnings Per Share () | 0.6994 | 0.4926 | +42.0 | 0.7210 |
| Announcement Date | 2025-08-26 | 2024-08-27 | NA | 2023-08-29 |
* Annualised
Last Update Time: 2025-09-08 21:40:25
